Ziconotide is a newer, intrathecal analgesic medication used for the treatment of chronic pain. Its FDA indication is for treating chronic severe pain in patients intolerant or refractory to systemic analgesics or intrathecal morphine. Ziconotide can only be administered intrathecally as it does not cross the blood-brain barrier well. It shows efficacy in treating intractable, severe, chronic pain secondary to cancer and non-malignant pain. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, toxicity, and monitoring, of ziconotide, so providers can direct patient therapy where it is indicated for pain relief as part of the interprofessional team.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/31465
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.5 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: All Practice Areas (e.g. ethics), Complex General Surgical Oncology, General Pediatrics, Hematology, Hospice & Palliative Medicine, Hospice and Palliative Medicine, Hospital Medicine, Internal Medicine, Medical Oncology, Pain Medicine, Pediatric Hematology-Oncology, Rheumatology, Surgery of the Spine
Subscribe
Login
0 Comments
Oldest